The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM

Journal of Hepatology

Volumn 25, Issue 5, 1996, Pages 621-626

  Stevenson, Donna L ^b   Harris, Amanda G ^b   Neal, Keith R ^b   Irving, William L ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NONE

Author keywords

Chronic hepatitis; Hepatitis C virus; IgM anti HCV; Rheumatoid factor

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 0030297484     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80229-7     Document Type: Article

References (21)

1. 1. Sjogren M, Hoofnagle JH. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Gastroenterology 1985; 89: 252-8.
2. 2. Quiroga JA, Campillo ML, Castillo I, Bartolome J, Porres JC, Carreno V. IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology 1991; 14: 38-43.
3. 3. Brillanti S, Masci C, Ricci P, Miglioli M, Barbara L. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C. Hepatology 1992; 15: 998-1001.
4. 4. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol 1994; 42: 311-7.
5. 5. Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Katayama K, Kasahara A, Fusamoto H, Kamada T. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers. J Hepatol 1994; 21: 110-4.
6. 6. Quiroga JA, Bosch O, Gonzalez R, Marriott E, Castillo I, Bartolome J, Carreno V. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C. Gastroenterology 1992; 103: 1285-9.
7. 7. Tabone M, Galatola G, Secreto P, Marini C, Molinaro G, Arico S. Serum levels of anti-hepatitis C virus IgM core antibodies may predict the response to interferon-alpha therapy in chronic hepatitis C. J Viral Hepatitis 1994; 1: 155-8
8. 8. Torronteras R, Sanchez-Quijano A, Abad MA, Soto B, Andreu J, Medrano EJ, Leal M, Lissen E. Predictive value of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C undergoing interferon-alpha therapy. Analysis by two different methods. J Viral Hepatitis 1994; 1: 159-62.
9. 9. Hellstrom UB, Sylvan SPE, Decker RH, Sonnerborg A. Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection. J Med Virol 1993; 39: 325-32.
10. 10. Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K, Akahane Y, Yoshizawa H, Okamoto H, Tsuda F, Peterson DA, Muchmore E. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; 336: 1400-3.
11. 11. Irving WL, Day S, Bennett D, Eglin RP, Flanagan P, Nuttall P, James V. The use of anti-GOR testing in the screening of blood donors for hepatitis C virus infection. Vox Sang 1993; 65: 38-41.
12. 12. Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, Bianchi FB. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258-9.
13. 13. Duclos-Vallee JC, Johanet C, Trinchet JC, Deny P, Laurent MF, Duron F, Valensi P, Weil B, Homberg JC, Paterton D, Beaugrand M. High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis. Br Med J 1994; 309: 846-7.
14. 14. Pawlotsky J-M, Ben Yahia M, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zafrani E-S, Duval J, Dhumeaux D. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-8.
15. 15. Salonen EM, Vaheri A, Suni J, Wager O. Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in enzyme immunoassay. J Infect Dis 1980; 142: 250-5.
16. 16. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
17. 17. Makris M, Preston FE, Triger DR, Underwood JCE, Westlake L, Adelman MI. A randomised controlled trial of recombinant interferon-alpha in chronic hepatitis C in haemophiliacs. Blood 1991; 78: 1672-7.
18. 18. Meurman O. Detection of antiviral IgM antibodies and its problems - a review. Current Topics in Microbiology and Immunology 1983; 104: 101-31.
19. 19. Pawlotsky J-M, Remire J, Darthuy F, Intrator L, Udin L, Dhumeaux D, Duval J. Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor? J Med Virol 1995; 45: 68-70.
20. 20. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci 1991; 88: 5462-6.
21. 21. Cerino A, Boender P, La Monica N, Rosa C, Habets W, Mondelli MU. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. J Immunol 1993; 151: 7005-15.